The Comparative Safety of Abciximab Versus Eptifibatide in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

OBJECTIVES: We sought to evaluate the patterns of use and outcomes associated with eptifibatide and abciximab administration among dialysis patients who underwent PCI. BACKGROUND: Contraindicated medications are frequently administered to dialysis patients undergoing PCI often resulting in adverse o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Interv Cardiol
Main Authors: Sukul, Devraj, Seth, Milan, Schreiber, Theodore, Hanzel, George, Khandelwal, Akshay, Cannon, Louis A., Lalonde, Thomas A., Gurm, Hitinder S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850214/
https://ncbi.nlm.nih.gov/pubmed/28543770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/joic.12388
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados